Cargando…
Safety and tolerability of switching to asenapine from other antipsychotic agents: pooled results from two randomized multicenter trials in stable patients with persistent negative symptoms in schizophrenia
BACKGROUND: In clinical practice, clinicians often need to switch antipsychotic medications in patients with schizophrenia to optimize treatment outcomes. Here, we describe the safety and tolerability of switching existing antipsychotic treatments to asenapine or olanzapine monotherapy using various...
Autores principales: | Cazorla, Pilar, Mackle, Mary, Zhao, Jun, Ha, Xianwei, Szegedi, Armin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3383320/ https://www.ncbi.nlm.nih.gov/pubmed/22745558 http://dx.doi.org/10.2147/NDT.S29891 |
Ejemplares similares
-
Comparison of somnolence associated with asenapine, olanzapine, risperidone, and haloperidol relative to placebo in patients with schizophrenia or bipolar disorder
por: Gao, Keming, et al.
Publicado: (2013) -
Asenapine effects on individual Young Mania Rating Scale items in bipolar disorder patients with acute manic or mixed episodes: a pooled analysis
por: Cazorla, Pilar, et al.
Publicado: (2013) -
Asenapine: an atypical antipsychotic with atypical
formulations
por: Musselman, Meghan, et al.
Publicado: (2021) -
Asenapine, a new sublingual atypical antipsychotic
por: Balaraman, R, et al.
Publicado: (2010) -
Effects of asenapine on depressive symptoms in patients with bipolar I disorder experiencing acute manic or mixed episodes: a post hoc analysis of two 3-week clinical trials
por: Szegedi, Armin, et al.
Publicado: (2011)